Press Releases

Please check back later for more content.

Trending on PharmExec

Roundup: Teva Acquires BXCL501 for $57.5 Million Upfront, Rumi Therapeutics Enters Option Agreement for Fragile X PDE2 Inhibitor From Enthorin

The Next Biopharma Revolution: Quantum Computing

How Medications like XOCOVA Prevent Illness After Exposure to COVID-19

Bristol Myers Squibb Discloses Patient Death in CAR-T Multiple Sclerosis Trial

Caution and Pharma’s AI Adoption: Understanding the Reasons Behind Uneven Uptake